Literature DB >> 21732370

Applications of circular dichroism (CD) for structural analysis of proteins: qualification of near- and far-UV CD for protein higher order structural analysis.

Cynthia H Li1, Xichdao Nguyen, Linda Narhi, Letha Chemmalil, Edward Towers, Salman Muzammil, John Gabrielson, Yijia Jiang.   

Abstract

Circular dichroism (CD) spectroscopy is routinely used in the biopharmaceutical industry to study the effects of manufacturing, formulation, and storage conditions on protein conformation and stability, and these results are often included in regulatory filings. In this context, the purpose of CD spectroscopy is often to verify that a change in the formulation or manufacturing process of a product has not produced a change in the conformation of a protein. A comparison of two or more spectra is often required to confirm that the protein's structure has been maintained. Traditionally, such comparisons have been qualitative in nature, based on visually inspecting the overlaid spectra. However, visual assessment is inherently subjective and therefore prone to error. Furthermore, recent requests from regulatory agencies to demonstrate the suitability of the CD spectroscopic method for the purpose of comparing spectra have highlighted the need to appropriately qualify CD spectroscopy for characterization of biopharmaceutical protein products. In this study, we use a numerical spectral comparison approach to establish the precision of the CD spectroscopic method and to demonstrate that it is suitable for protein structural characterization in numerous biopharmaceutical applications.
Copyright © 2011 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2011        PMID: 21732370     DOI: 10.1002/jps.22695

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Experimental characterization of adsorbed protein orientation, conformation, and bioactivity.

Authors:  Aby A Thyparambil; Yang Wei; Robert A Latour
Journal:  Biointerphases       Date:  2015-03-30       Impact factor: 2.456

2.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

3.  Protein helical structure determination using CD spectroscopy for solutions with strong background absorbance from 190 to 230nm.

Authors:  Yang Wei; Aby A Thyparambil; Robert A Latour
Journal:  Biochim Biophys Acta       Date:  2014-10-13

Review 4.  Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles.

Authors:  Mohammad A Alsenaidy; Nishant K Jain; Jae H Kim; C Russell Middaugh; David B Volkin
Journal:  Front Pharmacol       Date:  2014-03-12       Impact factor: 5.810

Review 5.  Quality assessment and optimization of purified protein samples: why and how?

Authors:  Bertrand Raynal; Pascal Lenormand; Bruno Baron; Sylviane Hoos; Patrick England
Journal:  Microb Cell Fact       Date:  2014-12-30       Impact factor: 5.328

6.  Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab).

Authors:  Juyong Hong; Yuhwa Lee; Changsoo Lee; Suhyeon Eo; Soyeon Kim; Nayoung Lee; Jongmin Park; Seungkyu Park; Donghyuck Seo; Min Jeong; Youngji Lee; Soojeong Yeon; George Bou-Assaf; Zoran Sosic; Wei Zhang; Orlando Jaquez
Journal:  MAbs       Date:  2016-12-22       Impact factor: 5.857

7.  Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product.

Authors:  Ramsey Saleem; Greg Cantin; Mats Wikström; Glen Bolton; Scott Kuhns; Helen J McBride; Jennifer Liu
Journal:  Pharm Res       Date:  2020-05-31       Impact factor: 4.200

8.  Enhancement of laccase activity by pre-incubation with organic solvents.

Authors:  Meng-Hsuan Wu; Meng-Chun Lin; Cheng-Chung Lee; Su-May Yu; Andrew H-J Wang; Tuan-Hua David Ho
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

9.  A Method for Producing Protein Nanoparticles with Applications in Vaccines.

Authors:  David S Jones; Christopher G Rowe; Beth Chen; Karine Reiter; Kelly M Rausch; David L Narum; Yimin Wu; Patrick E Duffy
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

10.  Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumab.

Authors:  Nayoung Lee; JongAh Joanne Lee; Hahymn Yang; Serim Baek; Soohwan Kim; Sooshin Kim; Tongkeun Lee; Dami Song; Gwangmin Park
Journal:  MAbs       Date:  2018-10-19       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.